Crossmark

Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population

Crossref DOI link: https://doi.org/10.1038/s41430-021-00950-1

Published Online: 2021-06-11

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, Anurag http://orcid.org/0000-0001-5717-4560
D’Amico, Davide

Andreux, Pénélope A.

Dunngalvin, Gillian

Kern, Timo

Blanco-Bose, William

Auwerx, Johan

Aebischer, Patrick

Rinsch, Chris
License Information

Text and Data Mining valid from 2021-06-11

Version of Record valid from 2021-06-11
More Information

Article History

Received: 25 January 2021

Revised: 7 May 2021

Accepted: 18 May 2021

First Online: 11 June 2021

Compliance with ethical standards

:

: The authors declare the following competing interests: AS, DD, PAA, WB-B, and CR are employees; PA and CR are board members; and JA and PA are members of the Scientific Advisory Board of Amazentis SA, who is the sponsor of this clinical study.

Document is current

Any future updates will be listed below